(40 days)
Not Found
No
The summary describes a physical medical device (embolic coil and delivery system) and does not mention any software, algorithms, or data processing that would indicate the use of AI or ML.
Yes
This device is intended for endovascular embolization of intracranial aneurysms, which is a therapeutic intervention.
No
This device is an embolic coil system used for endovascular embolization of intracranial aneurysms, which is a therapeutic (treatment) procedure, not a diagnostic one.
No
The device description explicitly states it consists of an embolic coil and a Device Positioning Unit (DPU), which are physical components, not software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "endovascular embolization of intracranial aneurysms." This describes a therapeutic procedure performed within the body (in vivo) to treat a medical condition.
- Device Description: The device consists of an embolic coil and a delivery system. These are physical devices used for a medical intervention, not for testing samples outside the body (in vitro).
- Lack of IVD Characteristics: The description does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Providing diagnostic information
- Using reagents or assays
IVDs are used to examine specimens obtained from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. This device is a therapeutic device used to treat a condition directly.
N/A
Intended Use / Indications for Use
The Micrus MicroCoil Delivery System is intended for endovascular embolization of intracranial aneurysms.
Product codes
HCG
Device Description
The Micrus Cashmere-14 MicroCoil System consists of an embolic coil ("MicroCoil") attached to a Device Positioning Unit (DPU) (single use, sterile).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
intracranial
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K022420, K002056, K042539, K032553
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.5950 Neurovascular embolization device.
(a)
Identification. A neurovascular embolization device is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral ateriovenous malformations. This does not include cyanoacrylates and other embolic agents, which act by polymerization or precipitation. Embolization devices used in other vascular applications are also not included in this classification, see § 870.3300.(b)
Classification. Class II (special controls.) The special control for this device is the FDA guidance document entitled “Class II Special Controls Guidance Document: Vascular and Neurovascular Embolization Devices.” For availability of this guidance document, see § 882.1(e).
0
K0626TS
1/2
1.4 Summary of Safety and Effectiveness
| Submitter Name and
Address: | Micrus Endovascular Corp.
821 Fox Lane
San Jose, CA 95131 | | JAN 17 2007 |
|------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|-------------|
| Contact Name: | Patrick Lee, Regulatory Affairs Specialist
Phone: 408-433-1428
Fax: 408-433-1401
Email: plee@micruscorp.com | | |
| Preparation Date: | December 5, 2006 | | |
| Device Name and
Classification: | Micrus Microcoil System "Cashmere"
Common Name: Micrus Microcoil System "Cashmere"
Classification Name: Device, Artificial Embolization | | |
| | Regulatory Class II | | |
| Predicate Devices: | Micrus Stretch-Resistant Microcoil, 510(k) no.K022420
Micrus Microcoil Delivery System, 510(k) no. K002056
Boston Scientific GDC 360 Soft SR, 510(k) no. K042539
Cordis Trufill DCS Orbit Detachable Coil, 510(k) no.K032553 | | |
| Device Description: | The Micrus Cashmere-14 MicroCoil System consists of an
embolic coil ("MicroCoil") attached to a Device Positioning
Unit (DPU) (single use, sterile). | | |
| Device Intended Use | The Micrus MicroCoil Delivery System is intended for
endovascular embolization of intracranial aneurysms. | | |
Comparison to Predicate Devices:
The Micrus Cashmere-14 Microcoil Systems have shown substantial equivalence to the Micrus SR Helical-18 Microcoil System in terms of intended use, design, material of construction, implant dimensions including wire diameter, primary wind diameter, pitch, coil stiffness, coil diameter, and coil length. The Cashmere-14 Microcoil system uses the same method and material of construction, packaging, and sterilization method as its predicate. The modification has not altered the fundamental technology of the sponsor's predicate device
The Micrus Cashmere-14 Microcoil System have also shown substantial equivalence to the Boston Scientific GDC 360 and Cordis Orbit microcoil predicates in terms of
1
2/2
intended use and design, material of construction, implant dimensions including wire diameter, primary wind diameter, pitch, coil stiffness, coil diameter, and coil length.
Conclusion:
Based upon the design, materials, function, intended use, comparison with currently marketed devices and the non-clinical testing performed by Micrus Endovascular Corporation, it is concluded that the Micrus Cashmere-14 Microcoil System is substantially equivalent to the predicate devices in safety and effectiveness.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Micrus Endovascular Corp. % Mr. Patrick Lee Regulatory Affairs Specialist 821 Fox Lane San Jose, California 95131
JAN 1 7 2007
Re: K063653
Trade/Device Name: Cashmere-14 MicroCoil System Regulation Number: 21 CFR 882.5950 Regulation Name: Neurovascular embolization device Regulatory Class: Class II Product Code: HCG Dated: December 6, 2006 Received: December 8, 2006
Dear Mr. Lee:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mr. Patrick Lee
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115 Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Melkerson
Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
K06361$\overline{3}$
Indications for Use
510(k) Number (if known): _
Micrus Microcoil System . "Cashmere" Device Name: _______________
Model #: SRC140512-20, SRC140615-20, SRC140717-20, SRC140820-20,
SRC140922-20, SRC141025-20, SRC141127-20, SRC141230-20
Indications For Use:
The Micrus MicroCoil Delivery System is intended for endovascular embolization of intracranial aneurysms.
Prescription Use _ AND/OR (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Division Sign-Off Division of General, Restorative, and Neurological Devices
Page 1 of 1
510(k) Number
Page 13